Decheng Capital LLC
Decheng Capital LLC is a US-based investment firm headquartered in Menlo Park, California. Founded in 2012, Decheng focuses on venture and growth investments within the healthcare and life sciences sectors, supporting companies developing innovative therapeutics, medical devices, and diagnostics. The firm manages assets for institutional investors and high-net-worth clients, and as of 2025, employs approximately 24 staff, with a majority as investment professionals.
Investment Strategy
Decheng Capital LLC pursues a venture capital and growth equity strategy targeting companies across biotechnology, pharmaceuticals, medical devices, and diagnostics. The firm’s approach centers around supporting transformative and disruptive healthcare innovations at various stages, from early clinical development to commercialization. Decheng invests globally, with a strong emphasis on companies pioneering scientific research and offering solutions to unmet medical needs, using deep domain expertise to select portfolio companies and actively support their growth.
Top Holdings
Equity Positions (24)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CGON | CG ONCOLOGY INC | 41.84% | $165.7M | 6,371,669 | $40.77 | $26.00 | +$9.6M |
A AARD | AARDVARK THERAPEUTICS INC | 13.38% | $53.0M | 3,917,299 | $7.51 | $13.52 | +$23.5M |
N NUVB | Nuvation Bio Inc. | 12.78% | $50.6M | 25,954,439 | $2.52 | $1.95 | +$4.9M |
U UPB | Upstream Bio Inc. | 9.11% | $36.1M | 3,285,293 | $16.44 | $10.98 | +$16.0M |
N NAMS | NEWAMSTERDAM PHARMA CO NV | 3.52% | $13.9M | 770,000 | $20.79 | $18.11 | -$1.8M |